首页 > 最新文献

Jordan Journal of Pharmaceutical Sciences最新文献

英文 中文
The Immunostimulatory Effect of Probiotic Conditioned Medium on RAW264.7 Murine Macrophages 益生菌条件培养基对RAW264.7小鼠巨噬细胞的免疫刺激作用
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-07-24 DOI: 10.35516/jjps.v16i2.1501
M. Barakat, M. Al-Najjar, S. Abdulrazzaq, Wamidh H. Talib, Tamara Athamneh
Background: Probiotics are a mixture of good live bacteria and/or yeasts that naturally survive in our bodies. Recently, loads of studies have focused on their role in the immune system and digestive tract. Accordingly, there are many commercially available probiotic products in the market. This study examines the immunostimulatory effect of commercially available-probiotic conditioned medium (PCM) on RAW264.7 murine macrophages. Methods: Probiotic conditioned medium has been prepared by culturing the commercially available probiotic in a cell culture medium overnight at 37°C, followed by centrifugation and filter-sterilization to be tested on RAW264.7 murine macrophages. The immunostimulatory effect of different ratios (50, 75, 100) of PCM was examined using MTT assay, pro-inflammatory cytokine (tumor necrosis factor TNF-alpha) production in macrophages., migration, and Phagocytosis assays. Results: At all the examined PCM ratios, the percentages of cell viability were >80%. Regarding the migration scratch, TNF-alpha and phagocytosis assays, PCM demonstrated a concentration-dependent pattern in the immunostimulatory effect. However, the ratio of 100 PCM illustrated a significant (p-value<0.05) stimulatory effect compared to the positive and negative control. Conclusion: The findings of this study confirm the stimulatory activity of probiotic conditioned medium, which may contribute directly to the immune-boosting effect of the probiotic supplements.
背景:益生菌是良好的活细菌和/或酵母的混合物,自然生存在我们的身体。最近,大量的研究集中在它们在免疫系统和消化道中的作用。因此,市场上有许多可买到的益生菌产品。本研究考察了市售益生菌条件培养基(PCM)对RAW264.7小鼠巨噬细胞的免疫刺激作用。方法:将市售益生菌在细胞培养基中37℃培养过夜,离心、过滤杀菌,制备益生菌条件培养基,对RAW264.7小鼠巨噬细胞进行检测。采用MTT法检测不同比例(50、75、100)PCM对巨噬细胞的免疫刺激作用,以及促炎细胞因子(肿瘤坏死因子tnf - α)的产生。迁移和吞噬试验。结果:在所有检测的PCM比例下,细胞存活率均为80%。在迁移划痕、tnf - α和吞噬实验中,PCM在免疫刺激作用中表现出浓度依赖性。但与正对照和负对照相比,100 PCM的比值表现出显著(p值<0.05)的刺激作用。结论:本研究结果证实了益生菌条件培养基的刺激作用,这可能是益生菌补充剂具有免疫增强作用的直接原因。
{"title":"The Immunostimulatory Effect of Probiotic Conditioned Medium on RAW264.7 Murine Macrophages","authors":"M. Barakat, M. Al-Najjar, S. Abdulrazzaq, Wamidh H. Talib, Tamara Athamneh","doi":"10.35516/jjps.v16i2.1501","DOIUrl":"https://doi.org/10.35516/jjps.v16i2.1501","url":null,"abstract":"Background: Probiotics are a mixture of good live bacteria and/or yeasts that naturally survive in our bodies. Recently, loads of studies have focused on their role in the immune system and digestive tract. Accordingly, there are many commercially available probiotic products in the market. This study examines the immunostimulatory effect of commercially available-probiotic conditioned medium (PCM) on RAW264.7 murine macrophages. \u0000Methods: Probiotic conditioned medium has been prepared by culturing the commercially available probiotic in a cell culture medium overnight at 37°C, followed by centrifugation and filter-sterilization to be tested on RAW264.7 murine macrophages. The immunostimulatory effect of different ratios (50, 75, 100) of PCM was examined using MTT assay, pro-inflammatory cytokine (tumor necrosis factor TNF-alpha) production in macrophages., migration, and Phagocytosis assays. \u0000Results: At all the examined PCM ratios, the percentages of cell viability were >80%. Regarding the migration scratch, TNF-alpha and phagocytosis assays, PCM demonstrated a concentration-dependent pattern in the immunostimulatory effect. However, the ratio of 100 PCM illustrated a significant (p-value<0.05) stimulatory effect compared to the positive and negative control. \u0000Conclusion: The findings of this study confirm the stimulatory activity of probiotic conditioned medium, which may contribute directly to the immune-boosting effect of the probiotic supplements.","PeriodicalId":14719,"journal":{"name":"Jordan Journal of Pharmaceutical Sciences","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46727369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metal Chelators as Anticancer Approach: Part I; Novel 7-Anisidine Derivatives with Multidentate at 7-8 Carbons of Fluoroquinolone Scaffold as Potential Chelator Anticancer and Antilipolytic Candidates 金属螯合剂作为抗癌药物的研究方法:第一部分;氟喹诺酮支架7-8个碳原子上具有多齿结构的新型7-苯胺衍生物作为潜在的螯合物抗癌和抗脂蛋白候选物
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-07-24 DOI: 10.35516/jjps.v16i2.1467
Y. Al-Hiari, Shereen Arabiyat, V. Kasabri, I. Hamdan, I. Almasri, M. Yasin, Dalya Al-Saad
Background: Cancer is one of the greatest troubling maladies currently. It is believed that it is the second reason for death following cardiovascular maladies. Owing to the multiplicity of its types, stages and genetic basis, there is no existing drug to cure all types of cancer. Resistance to present drugs and severe adverse effects are other challenges in the struggle against cancer. In such pursuit, fluoroquinolones (FQs) have the potential as antiproliferative compounds due to safety, low cost, and absence of resistance. Aims: In this study, we aim to synthesize biologically active compounds that have dual anticancer and anti-lipase potential. Sixteen compounds were prepared, fully characterized, and studied through identification of IC50 values against the highly susceptible cancer cell lines. Methods: In this work we are concerned with synthesizing biologically active compounds that belong to fluoroquinolones (FQs) with dual anti-colorectal cancer and anti-lipase activity, owing to association between cancer and obesity, conduct titration and docking experiments to validate our hypothesis. Results: In vitro findings indicated that these compounds demonstrated promising anticancer activity against tested cell lines in micromolar range with a potency comparable to cisplatin. Compound 11 exhibited approximately doubled potency compared to cisplatin against SW620 colorectal cancer cell line with IC50 3.2 μM which proposes FQs as potent antiproliferative agents. The synthesized Fluoroquinolone (FQ) compounds were further screened for their in vitro anti-lipase potential. The findings demonstrated that all the screened compounds have demonstrated remarkable anti-lipase activity, as compared to control molecule orlistat. Compound 9 exhibited comparable activity to orlistat against pancreatic lipase with IC50 0.4 μM which proposes FQs as potent pancreatic lipase inhibitors. Conclusions: The anticancer potential of these derivatives is referred to their ability to inhibit Topo II which indicates that chelation is the mechanism of inhibition of Topo II emphasized with titration and docking experiments.
背景:癌症是目前最令人困扰的疾病之一。据信,这是继心血管疾病之后死亡的第二个原因。由于其类型、阶段和遗传基础的多样性,目前还没有治愈所有类型癌症的药物。对现有药物的耐药性和严重的不良反应是对抗癌症的其他挑战。在这种追求中,氟喹诺酮类药物由于安全、低成本和无耐药性而具有作为抗增殖化合物的潜力。目的:本研究旨在合成具有抗癌和抗脂肪酶双重潜力的生物活性化合物。制备了16种化合物,对其进行了充分表征,并通过鉴定对高度易感的癌症细胞系的IC50值进行了研究。方法:由于癌症与肥胖之间的关系,我们致力于合成具有双重抗直肠癌症和抗脂肪酶活性的氟喹诺酮类生物活性化合物,并进行滴定和对接实验来验证我们的假设。结果:体外研究结果表明,这些化合物在微摩尔范围内对测试的细胞系表现出有希望的抗癌活性,其效力与顺铂相当。与具有IC50 3.2μM的针对SW620结直肠癌癌症细胞系的顺铂相比,化合物11表现出大约加倍的效力,其提出FQs作为有效的抗增殖剂。进一步筛选了合成的氟喹诺酮类化合物的体外抗脂肪酶活性。研究结果表明,与对照分子奥利司他相比,所有筛选的化合物都表现出显著的抗脂肪酶活性。化合物9对胰脂肪酶表现出与奥利司他相当的活性,IC50为0.4μM,这表明FQs是有效的胰脂肪酶抑制剂。结论:这些衍生物的抗癌潜力是指它们抑制Topo II的能力,这表明螯合作用是滴定和对接实验强调的Topo II抑制机制。
{"title":"Metal Chelators as Anticancer Approach: Part I; Novel 7-Anisidine Derivatives with Multidentate at 7-8 Carbons of Fluoroquinolone Scaffold as Potential Chelator Anticancer and Antilipolytic Candidates","authors":"Y. Al-Hiari, Shereen Arabiyat, V. Kasabri, I. Hamdan, I. Almasri, M. Yasin, Dalya Al-Saad","doi":"10.35516/jjps.v16i2.1467","DOIUrl":"https://doi.org/10.35516/jjps.v16i2.1467","url":null,"abstract":"Background: Cancer is one of the greatest troubling maladies currently. It is believed that it is the second reason for death following cardiovascular maladies. Owing to the multiplicity of its types, stages and genetic basis, there is no existing drug to cure all types of cancer. Resistance to present drugs and severe adverse effects are other challenges in the struggle against cancer. In such pursuit, fluoroquinolones (FQs) have the potential as antiproliferative compounds due to safety, low cost, and absence of resistance. \u0000Aims: In this study, we aim to synthesize biologically active compounds that have dual anticancer and anti-lipase potential. Sixteen compounds were prepared, fully characterized, and studied through identification of IC50 values against the highly susceptible cancer cell lines. \u0000Methods: In this work we are concerned with synthesizing biologically active compounds that belong to fluoroquinolones (FQs) with dual anti-colorectal cancer and anti-lipase activity, owing to association between cancer and obesity, conduct titration and docking experiments to validate our hypothesis. \u0000Results: In vitro findings indicated that these compounds demonstrated promising anticancer activity against tested cell lines in micromolar range with a potency comparable to cisplatin. Compound 11 exhibited approximately doubled potency compared to cisplatin against SW620 colorectal cancer cell line with IC50 3.2 μM which proposes FQs as potent antiproliferative agents. The synthesized Fluoroquinolone (FQ) compounds were further screened for their in vitro anti-lipase potential. The findings demonstrated that all the screened compounds have demonstrated remarkable anti-lipase activity, as compared to control molecule orlistat. Compound 9 exhibited comparable activity to orlistat against pancreatic lipase with IC50 0.4 μM which proposes FQs as potent pancreatic lipase inhibitors. \u0000Conclusions: The anticancer potential of these derivatives is referred to their ability to inhibit Topo II which indicates that chelation is the mechanism of inhibition of Topo II emphasized with titration and docking experiments.","PeriodicalId":14719,"journal":{"name":"Jordan Journal of Pharmaceutical Sciences","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43306100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Crosslinking of Water-Soluble Cyclodextrin with Hyaluronic Acid for Targeted Drug Delivery 水溶性环糊精与透明质酸交联的靶向给药研究
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-07-24 DOI: 10.35516/jjps.v16i2.1497
Fedaa Adaileh
Introduction: Most of the cytotoxic anticancer drugs belong to substances with both low solubility in aqueous fluids and poor cellular uptake, which lead to lack of specific therapy with apparent side effects. Therefore, there is a need to develop a novel drug delivery that can remotely and selectively release their payload. Curcumin(CUR) is an antibiotic, also a powerful inhibitor of the proliferation of several tumor cells. Aims: The aim of the present work is to highlight and discussed hyaluronic acid (HA ) to be grafted with Mono-6-deoxyl-6-ethylenediamino-γ-cyclodextrin (ɣ-CD-EDA) to shape a hydrogel that ought to structure inclusion complexes with curcumin, bettering its water-solubility and serving as a model drug delivery system Methods: Distinct copolymers had been organized HA grafted with ɣ-cyclodextrin (ɣ-CD-EDA) to form a hydrogel with various HA: ɣ-CD-EDA ratios and characterized, by means of 1H-NMR spectroscopy, zeta potential, Thermogravimetry analysis) TGA) Differential scanning calorimetry (DSC), and transmission electron microscopy (TEM). Furthermore, drug loading Encapsulation efficiency (EE%), and release kinetics, and stability. Also, cytotoxicity and uptake were assessed by flow cytometry, MTT assay and confocal laser microscopy. Wound healing activity was once improved using three cell MDA-MB-231, MCF-7, and fibroblast. Measuring the effect of HA-γ-CD-EDA1-CUR, γ-CD-EDA1-CUR, and CUR free on the Production and Secretion of inflammatory cytokines Result: CUR loading potential used to be at once correlated with extended HA-ɣ-CD-EDA composition and morphological adjustments have been discovered upon CUR binding. The host substances and their CUR inclusion complexes are no longer cytotoxic, and consequently beneficial for CUR and drug delivery. Moreover, HA-γ-CD-EDA1-CUR, γ-CD-EDA1-CUR, and CUR wound healing activity was once improved, and human promonocytic THP-1 cells produce inflammatory mediators such as IL-1β, IL10,IL8, TNF-α,IRAKI and IL6 results showed that the combination HA-γ-CD-EDA1-CUR could be suitable to reduce inflammation and the complex promoted the anti-inflammatory effect by the inhibition of inflammatory mediators. Conclusion: HA grafted with ɣ-cyclodextrin (ɣ-CD-EDA) to form a hydrogel was designed, formulated, and full characterized. Nanoparticles were stable at physiological pH and have released payload. Encapsulation of CUR into polymer increased its selectivity, distribution, and accumulation into the cancer cells. HA-CD-EDA1conjugated curcumin if incorporated in suitable matrix has a potential utility for treatment of wound, and down regulation in THP-1 cells.
导读:大多数细胞毒性抗癌药物属于在水溶液中溶解度低和细胞摄取差的物质,这导致缺乏特异性治疗且副作用明显。因此,有必要开发一种新的药物递送方式,可以远程和选择性地释放其有效载荷。姜黄素(Curcumin, CUR)是一种抗生素,也是几种肿瘤细胞增殖的有效抑制剂。目的:研究透明质酸(HA)与单-6-脱氧-6-乙二氨基-γ-环糊精(HA -CD-EDA)接枝形成的水凝胶与姜黄素包合物的结构,提高其水溶性,并作为一种模型药物递送系统。方法:用不同的共聚物接枝HA -环糊精(HA -CD-EDA),形成具有不同HA的水凝胶。通过1H-NMR, zeta电位,热重分析(TGA),差示扫描量热法(DSC)和透射电子显微镜(TEM)对其进行了表征。此外,还考察了载药包封效率(EE%)、释药动力学和稳定性。用流式细胞术、MTT法和激光共聚焦显微镜观察细胞毒性和摄取情况。使用三细胞MDA-MB-231、MCF-7和成纤维细胞,伤口愈合活性一度得到改善。测定HA-γ-CD-EDA1-CUR、γ-CD-EDA1-CUR和游离CUR对炎症细胞因子产生和分泌的影响结果:过去,CUR的负载电位与HA- α - cd - eda的扩展组成立即相关,并且在CUR结合后发现形态上的调整。宿主物质及其CUR包合物不再具有细胞毒性,因此有利于CUR和药物递送。此外,HA-γ-CD-EDA1-CUR、γ-CD-EDA1-CUR、CUR的创面愈合活性一度提高,人造血原细胞THP-1细胞产生IL-1β、il - 10、il - 8、TNF-α、IRAKI、il - 6等炎症介质。结果表明,HA-γ-CD-EDA1-CUR联合可适用于减轻炎症,复合物通过抑制炎症介质促进抗炎作用。结论:设计、制备并表征了羟基透明质酸与-环糊精(-CD-EDA)接枝形成的水凝胶。纳米颗粒在生理pH值下稳定,并释放有效载荷。将CUR包封在聚合物中,增加了其在癌细胞中的选择性、分布和积累。ha - cd - eda1结合的姜黄素如果掺入合适的基质中,在伤口治疗和THP-1细胞下调方面具有潜在的应用价值。
{"title":"Crosslinking of Water-Soluble Cyclodextrin with Hyaluronic Acid for Targeted Drug Delivery","authors":"Fedaa Adaileh","doi":"10.35516/jjps.v16i2.1497","DOIUrl":"https://doi.org/10.35516/jjps.v16i2.1497","url":null,"abstract":"Introduction: Most of the cytotoxic anticancer drugs belong to substances with both low solubility in aqueous fluids and poor cellular uptake, which lead to lack of specific therapy with apparent side effects. Therefore, there is a need to develop a novel drug delivery that can remotely and selectively release their payload. Curcumin(CUR) is an antibiotic, also a powerful inhibitor of the proliferation of several tumor cells. \u0000Aims: The aim of the present work is to highlight and discussed hyaluronic acid (HA ) to be grafted with Mono-6-deoxyl-6-ethylenediamino-γ-cyclodextrin (ɣ-CD-EDA) to shape a hydrogel that ought to structure inclusion complexes with curcumin, bettering its water-solubility and serving as a model drug delivery system \u0000Methods: Distinct copolymers had been organized HA grafted with ɣ-cyclodextrin (ɣ-CD-EDA) to form a hydrogel with various HA: ɣ-CD-EDA ratios and characterized, \u0000by means of 1H-NMR spectroscopy, zeta potential, Thermogravimetry analysis) TGA) Differential scanning calorimetry (DSC), and transmission electron microscopy (TEM). Furthermore, drug loading Encapsulation efficiency (EE%), and release kinetics, and stability. Also, cytotoxicity and uptake were assessed by flow cytometry, MTT assay and confocal laser microscopy. Wound healing activity was once improved using three cell MDA-MB-231, MCF-7, and fibroblast. Measuring the effect of HA-γ-CD-EDA1-CUR, γ-CD-EDA1-CUR, and CUR free on the Production and Secretion of inflammatory cytokines \u0000Result: CUR loading potential used to be at once correlated with extended HA-ɣ-CD-EDA composition and morphological adjustments have been discovered upon CUR binding. The host substances and their CUR inclusion complexes are no longer cytotoxic, and consequently beneficial for CUR and drug delivery. Moreover, HA-γ-CD-EDA1-CUR, γ-CD-EDA1-CUR, and CUR wound healing activity was once improved, and human promonocytic THP-1 cells produce inflammatory mediators such as IL-1β, IL10,IL8, TNF-α,IRAKI and IL6 results showed that the combination HA-γ-CD-EDA1-CUR could be suitable to reduce inflammation and the complex promoted the anti-inflammatory effect by the inhibition of inflammatory mediators. \u0000Conclusion: HA grafted with ɣ-cyclodextrin (ɣ-CD-EDA) to form a hydrogel was designed, formulated, and full characterized. Nanoparticles were stable at physiological pH and have released payload. Encapsulation of CUR into polymer increased its selectivity, distribution, and accumulation into the cancer cells. HA-CD-EDA1conjugated curcumin if incorporated in suitable matrix has a potential utility for treatment of wound, and down regulation in THP-1 cells.","PeriodicalId":14719,"journal":{"name":"Jordan Journal of Pharmaceutical Sciences","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42533292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Progress in the Design and Development of Phosphoinositide-3-Kinase (PI3Kα) Inhibitors 磷酸肌苷-3-激酶(PI3Kα)抑制剂的设计与开发进展
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-07-24 DOI: 10.35516/jjps.v16i2.1489
D. Sabbah
Background: The phosphatidylinositol 3-kinase (PI3Kα) has been spotlighted as a potential oncogene and therapeutic target for anticancer drug design. Objective: Target compounds were designed employing ligand- and structure-based drug design approaches to address the effect of the compounds’ backbones and functionalities on their biological activity. Methods: Synthesis of the targeted compounds, biological evaluation tests against human cancer cell lines, and molecular docking studies. Results: Fortunately, 20 novel series of diverse scaffolds were prepared and characterized by means of FT-IR, 1H and 13C NMR, HRMS, and elemental analysis. In addition, the identity of one core nucleus was successfully interpreted with the aid of X-ray crystallography. Biological activity of prepared compounds was investigated in vitro against human cancer cell lines. Results that these compounds inhibit cell proliferation and induce apoptosis through an increase in caspase-3 activity and a decrease in DNA cellular content. Furthermore, ligand-based pharmacophore modeling showed that the newly synthesized analogues match PI3Kα inhibitors fingerprint and the molecular docking studies against PI3Kα revealed that the analogues fit PI3Kα kinase catalytic domain and form H-bonding with key binding residues. Conclusion: The harvested series exhibited a potential PI3Kα inhibitory activity in human cancer cell lines.
背景:磷脂酰肌醇3-激酶(PI3Kα)是一种潜在的致癌基因和抗癌药物设计的治疗靶点。目的:采用基于配体和结构的药物设计方法设计目标化合物,以解决化合物的骨架和功能对其生物活性的影响。方法:靶向化合物的合成、对人癌症细胞系的生物学评价和分子对接研究。结果:幸运的是,制备了20个新系列的不同支架,并通过FT-IR、1H和13C NMR、HRMS和元素分析进行了表征。此外,在X射线晶体学的帮助下,成功地解释了一个核心核的身份。研究了制备的化合物对人癌症细胞系的体外生物学活性。结果这些化合物通过增加胱天蛋白酶-3活性和降低DNA细胞含量来抑制细胞增殖并诱导细胞凋亡。此外,基于配体的药效团建模表明,新合成的类似物与PI3Kα抑制剂指纹图谱相匹配,针对PI3K a的分子对接研究表明,这些类似物符合PI3K a-激酶催化结构域,并与关键结合残基形成氢键。结论:收获的系列对人癌症细胞株具有潜在的PI3Kα抑制活性。
{"title":"Progress in the Design and Development of Phosphoinositide-3-Kinase (PI3Kα) Inhibitors","authors":"D. Sabbah","doi":"10.35516/jjps.v16i2.1489","DOIUrl":"https://doi.org/10.35516/jjps.v16i2.1489","url":null,"abstract":"Background: The phosphatidylinositol 3-kinase (PI3Kα) has been spotlighted as a potential oncogene and therapeutic target for anticancer drug design. \u0000Objective: Target compounds were designed employing ligand- and structure-based drug design approaches to address the effect of the compounds’ backbones and functionalities on their biological activity. \u0000Methods: Synthesis of the targeted compounds, biological evaluation tests against human cancer cell lines, and molecular docking studies. \u0000Results: Fortunately, 20 novel series of diverse scaffolds were prepared and characterized by means of FT-IR, 1H and 13C NMR, HRMS, and elemental analysis. In addition, the identity of one core nucleus was successfully interpreted with the aid of X-ray crystallography. Biological activity of prepared compounds was investigated in vitro against human cancer cell lines. Results that these compounds inhibit cell proliferation and induce apoptosis through an increase in caspase-3 activity and a decrease in DNA cellular content. Furthermore, ligand-based pharmacophore modeling showed that the newly synthesized analogues match PI3Kα inhibitors fingerprint and the molecular docking studies against PI3Kα revealed that the analogues fit PI3Kα kinase catalytic domain and form H-bonding with key binding residues. \u0000Conclusion: The harvested series exhibited a potential PI3Kα inhibitory activity in human cancer cell lines.","PeriodicalId":14719,"journal":{"name":"Jordan Journal of Pharmaceutical Sciences","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47541583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phytochemical Screening and Diuretic Activity of selected Palestinian Medicinal plants in Mice using an Aqueous Extract Division of Physiology, Pharmacology and Toxicology 利用生理、药理学和毒理学的水萃取物筛选巴勒斯坦药用植物在小鼠体内的植物化学和利尿活性
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-07-24 DOI: 10.35516/jjps.v16i2.1510
B. Rahhal, Isra N. Taha, Insaf Najajreh, W. Basha, Hamzeh Alzabadeh, A. Zyoud, Areen Sharaga, Zanab Alratrout, Nima Yunis, Ola Kanaan, Jenan Raddad, Tasneem Yousef
Purpose: Man used various natural materials as a remedy for the treatment of various diseases and recently witnessed a vastly growing and renewed interest in herbal medicine globally. In Palestinian folk medicine, Crataegus aronia, Rosmarinus officinalis known as rosemary and Nigella sativa is used as a diuretic and for treatment of hypertension. This study aimed to assess the preliminary phytochemical properties and the diuretic effect of the aqueous extracts of these plants in mice after its intraperitonial administration. Methods: It is an experimental trial applied on mice (n=8, Male, CD-1, weight range: [25-30 gram]), which are divided into two groups (4 in each). The first group administered with the plant extract (500 mg/kg), and the second with normal saline as negative control group. Then urine output and electrolyte contents were quantified up to 6 hours for the three groups and then compared to the control one. Results: Preliminary phytochemical screening reveals the presence of tannins, alkaloids and flavoniods as major phytoconstituents in aqueous extract. Significant diuresis was noted in those received the aqueous extract of Crataegus aronia (p < 0.05) compared to controls. Moreover, aqueous extract had an acidic pH and a mild increase in the electrolyte excretion (Na, K).On the contrary, the aqueous extracts from the Rosemary and Nigella sativa showed no diuretic activity. Conclusions: Our results revealed that Crataegus aronia aqueous extract has a significant potential diuretic effect. Further studies are needed to evaluate this diuretic effect in the relief of diseases characterized by volume overload.
目的:人类使用各种天然材料作为治疗各种疾病的药物,最近见证了全球对草药的兴趣不断增长和更新。在巴勒斯坦民间医学中,山楂、迷迭香和Nigella sativa被用作利尿剂和治疗高血压。本研究旨在评估这些植物的水提取物在腹腔给药后对小鼠的初步植物化学性质和利尿作用。方法:在小鼠(n=8,雄性,CD-1,体重范围:[25-30克])上进行实验试验,将其分为两组(每组4只)。第一组给予植物提取物(500mg/kg),第二组给予生理盐水作为阴性对照组。然后对三组的尿量和电解质含量进行定量,直到6小时,然后与对照组进行比较。结果:初步植物化学筛选结果表明,水提物中主要含有鞣质、生物碱和黄酮类化合物。在接受山楂水提取物的患者中观察到显著的利尿作用(p < 0.05)。此外,水提取物的pH值呈酸性,电解质排泄量(Na,K)略有增加。相反,迷迭香和奈杰尔拉的水提取物没有显示出利尿活性。结论:我们的研究结果表明,山楂水提取物具有显著的潜在利尿作用。需要进一步的研究来评估这种利尿作用对以容量过载为特征的疾病的缓解作用。
{"title":"Phytochemical Screening and Diuretic Activity of selected Palestinian Medicinal plants in Mice using an Aqueous Extract Division of Physiology, Pharmacology and Toxicology","authors":"B. Rahhal, Isra N. Taha, Insaf Najajreh, W. Basha, Hamzeh Alzabadeh, A. Zyoud, Areen Sharaga, Zanab Alratrout, Nima Yunis, Ola Kanaan, Jenan Raddad, Tasneem Yousef","doi":"10.35516/jjps.v16i2.1510","DOIUrl":"https://doi.org/10.35516/jjps.v16i2.1510","url":null,"abstract":"Purpose: Man used various natural materials as a remedy for the treatment of various diseases and recently witnessed a vastly growing and renewed interest in herbal medicine globally. In Palestinian folk medicine, Crataegus aronia, Rosmarinus officinalis known as rosemary and Nigella sativa is used as a diuretic and for treatment of hypertension. This study aimed to assess the preliminary phytochemical properties and the diuretic effect of the aqueous extracts of these plants in mice after its intraperitonial administration. \u0000Methods: It is an experimental trial applied on mice (n=8, Male, CD-1, weight range: [25-30 gram]), which are divided into two groups (4 in each). The first group administered with the plant extract (500 mg/kg), and the second with normal saline as negative control group. Then urine output and electrolyte contents were quantified up to 6 hours for the three groups and then compared to the control one. \u0000Results: Preliminary phytochemical screening reveals the presence of tannins, alkaloids and flavoniods as major phytoconstituents in aqueous extract. Significant diuresis was noted in those received the aqueous extract of Crataegus aronia (p < 0.05) compared to controls. Moreover, aqueous extract had an acidic pH and a mild increase in the electrolyte excretion (Na, K).On the contrary, the aqueous extracts from the Rosemary and Nigella sativa showed no diuretic activity. \u0000Conclusions: Our results revealed that Crataegus aronia aqueous extract has a significant potential diuretic effect. Further studies are needed to evaluate this diuretic effect in the relief of diseases characterized by volume overload.","PeriodicalId":14719,"journal":{"name":"Jordan Journal of Pharmaceutical Sciences","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41809653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The Use of Zebrafish and in Vivo PAL as a Novel Discovery Platform for Psychoactive Agents 斑马鱼和体内PAL作为精神活性剂新发现平台的应用
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-07-24 DOI: 10.35516/jjps.v16i2.1498
F. Williams
Our research is utilizing the zebrafish model to study molecular processes and animal models of human diseases. These studies discussed here start to assess how different bath salts and methamphetaminecause death upon overdose by addressing the molecules that may bind to the illicit drugs. We have accomplished this by developing an in vivo photo-affinity labelling (PAL) system and studying the drugs in our system. The zebrafish has been lauded as a unique and powerful tool to examine development in a vertebrate animal and address molecular aspects of human disease for decades. We will examine recent published data from our laboratory utilizing the PAL system we developed.
我们的研究利用斑马鱼模型来研究人类疾病的分子过程和动物模型。这里讨论的这些研究开始评估不同的浴盐和甲基苯丙胺如何通过解决可能与非法药物结合的分子而导致过量死亡。我们通过开发体内光亲和标记(PAL)系统和研究系统中的药物来实现这一目标。几十年来,斑马鱼一直被誉为研究脊椎动物发育和解决人类疾病分子方面问题的独特而强大的工具。我们将利用我们开发的PAL系统检查实验室最近公布的数据。
{"title":"The Use of Zebrafish and in Vivo PAL as a Novel Discovery Platform for Psychoactive Agents","authors":"F. Williams","doi":"10.35516/jjps.v16i2.1498","DOIUrl":"https://doi.org/10.35516/jjps.v16i2.1498","url":null,"abstract":"Our research is utilizing the zebrafish model to study molecular processes and animal models of human diseases. These studies discussed here start to assess how different bath salts and methamphetaminecause death upon overdose by addressing the molecules that may bind to the illicit drugs. We have accomplished this by developing an in vivo photo-affinity labelling (PAL) system and studying the drugs in our system. The zebrafish has been lauded as a unique and powerful tool to examine development in a vertebrate animal and address molecular aspects of human disease for decades. We will examine recent published data from our laboratory utilizing the PAL system we developed.","PeriodicalId":14719,"journal":{"name":"Jordan Journal of Pharmaceutical Sciences","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42673999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Treatment of Macrophages with Gram-Negative and -Positive Bacterial Secretomes Induce Distinct Metabolic Signatures 革兰氏阴性和阳性细菌分泌体治疗巨噬细胞可诱导不同的代谢特征
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-07-24 DOI: 10.35516/jjps.v16i2.1508
Alaa Abuawad
Infectious diseases represent major health and economic challenges globally. Emergence of multiple drug-resistant bacteria in the community and hospital has become a worldwide concern that requires novel approaches for rapid diagnosis and treatment. Metabolomics approach is a powerful tool providing important chemical information about the cellular phenotype of living systems, and the changes in their metabolic pathways in response to various perturbations. Metabolomics has become an important tool to study host-pathogen interactions and to discover potential novel therapeutic targets. In this study, untargeted LC-MS metabolic profiling was applied to differentiate between the impact of the secretome of the Gram-positive S. aureus SH1000 and Gram-negative P. aeruginosa PAO1 bacterial pathogens on THP-1 macrophages. The results showed that S. aureus and P. aeruginosa secretome affected alanine, aspartate and glutamate metabolism; sphingolipid metabolism; glycine and serine metabolism; GL metabolism; and tryptophan metabolism with different trends in THP-1 macrophages. However, the impact of both bacterial secretome on arginine and proline metabolism was similar. These data could contribute to a better understanding of pathogenesis and resistance of these bacteria and could pave the way for developing new therapeutics that selectively targeting Gram-positive or Gram-negative bacteria.
传染病是全球主要的健康和经济挑战。社区和医院中出现的多重耐药细菌已成为全世界关注的问题,需要采用新的方法进行快速诊断和治疗。代谢组学方法是一种强大的工具,提供了关于生命系统细胞表型的重要化学信息,以及它们的代谢途径在各种扰动下的变化。代谢组学已成为研究宿主-病原体相互作用和发现潜在新治疗靶点的重要工具。在本研究中,采用非靶向LC-MS代谢谱来区分革兰氏阳性金黄色葡萄球菌SH1000和革兰氏阴性铜绿假单胞菌PAO1细菌病原体分泌组对THP-1巨噬细胞的影响。结果表明,金黄色葡萄球菌和铜绿假单胞菌分泌组影响丙氨酸、天冬氨酸和谷氨酸代谢;鞘脂类代谢;甘氨酸和丝氨酸代谢;GL新陈代谢;THP-1巨噬细胞色氨酸代谢的变化趋势。然而,细菌分泌组对精氨酸和脯氨酸代谢的影响是相似的。这些数据有助于更好地了解这些细菌的发病机制和耐药性,并为开发选择性靶向革兰氏阳性或革兰氏阴性细菌的新疗法铺平道路。
{"title":"Treatment of Macrophages with Gram-Negative and -Positive Bacterial Secretomes Induce Distinct Metabolic Signatures","authors":"Alaa Abuawad","doi":"10.35516/jjps.v16i2.1508","DOIUrl":"https://doi.org/10.35516/jjps.v16i2.1508","url":null,"abstract":"Infectious diseases represent major health and economic challenges globally. Emergence of multiple drug-resistant bacteria in the community and hospital has become a worldwide concern that requires novel approaches for rapid diagnosis and treatment. Metabolomics approach is a powerful tool providing important chemical information about the cellular phenotype of living systems, and the changes in their metabolic pathways in response to various perturbations. Metabolomics has become an important tool to study host-pathogen interactions and to discover potential novel therapeutic targets. In this study, untargeted LC-MS metabolic profiling was applied to differentiate between the impact of the secretome of the Gram-positive S. aureus SH1000 and Gram-negative P. aeruginosa PAO1 bacterial pathogens on THP-1 macrophages. The results showed that S. aureus and P. aeruginosa secretome affected alanine, aspartate and glutamate metabolism; sphingolipid metabolism; glycine and serine metabolism; GL metabolism; and tryptophan metabolism with different trends in THP-1 macrophages. However, the impact of both bacterial secretome on arginine and proline metabolism was similar. These data could contribute to a better understanding of pathogenesis and resistance of these bacteria and could pave the way for developing new therapeutics that selectively targeting Gram-positive or Gram-negative bacteria.","PeriodicalId":14719,"journal":{"name":"Jordan Journal of Pharmaceutical Sciences","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41325040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preparation, in vitro and in vivo evaluation of solid-in-oil dispersion-based formulation the anti-glaucoma drug, timolol maleate 基于油包固体分散体的制剂的制备、体外和体内评价抗青光眼药物马来酸噻吗洛尔
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-07-24 DOI: 10.35516/jjps.v16i2.1533
Noor Barakat, Mai Jaber, Hatim S Alkhatib
Lowering Intraocular pressure (IOP) is a main therapeutic objective in glaucoma patients because IOP is an important risk factor for glaucoma progression. The objective of this work was to formulate and evaluate, in vitro and in vivo, a stable and effective Solid in Oil (S/O) topical formulation of the antiglaucoma drug, timolol maleate (TM). S/O dispersions were prepared by emulsification of aqueous TM solutions in cyclohexane using different amount of the span 85 then lyophilizing the emulsion to produce TM – Span 85 complexes. The complexes were then dispersed in castor oil using tip sonicator to produce S/O nanodispersions. S/O nanodispersions were evaluated in terms of particle size, polydispersity index, encapsulation efficiency, morphology, physical stability, as well as transcorneal permeation and accumulation of TM. In addition, the in vivo tolerability and efficacy of the prepared formulation in lowering intraocular pressure were evaluated in rabbits. Spherical nanoparticles of TM with a particle size of about 134-155 nm were successfully prepared and found to be physically stable. The encapsulation efficiency was high and was found to be dependent on the level of Span 85 used. In comparison to TM solution, S/O nanodispersion enhanced TM permeation and decreased accumulation in transcorneal diffusion studies. In addition, application TM S/O nanodispersion onto rabbit eyes resulted in a significant reduction in IOP in comparison to TM aqueous solution.
降低眼压是青光眼患者的主要治疗目标,因为眼压是青光眼进展的重要风险因素。本工作的目的是在体外和体内配制和评估一种稳定有效的抗青光眼药物马来酸噻吗洛尔(TM)的油包固体(S/O)局部制剂。通过使用不同量的Span85将TM水溶液在环己烷中乳化,然后冷冻干燥乳液以制备TM–Span85复合物,制备了S/O分散体。然后使用尖端超声仪将复合物分散在蓖麻油中以制备S/O纳米分散体。从粒径、多分散指数、包封效率、形态、物理稳定性以及TM的经角膜渗透和积累等方面评估了S/O纳米分散体。此外,还评估了所制备的制剂在兔体内降低眼压的耐受性和疗效。成功制备了粒径约为134-155nm的TM球形纳米颗粒,并发现其物理稳定。封装效率高,并且发现其取决于所使用的Span 85的水平。与TM溶液相比,S/O纳米分散体在跨角膜扩散研究中增强了TM的渗透并减少了积累。此外,与TM水溶液相比,将TM S/O纳米分散体应用于兔眼导致IOP显著降低。
{"title":"Preparation, in vitro and in vivo evaluation of solid-in-oil dispersion-based formulation the anti-glaucoma drug, timolol maleate","authors":"Noor Barakat, Mai Jaber, Hatim S Alkhatib","doi":"10.35516/jjps.v16i2.1533","DOIUrl":"https://doi.org/10.35516/jjps.v16i2.1533","url":null,"abstract":"Lowering Intraocular pressure (IOP) is a main therapeutic objective in glaucoma patients because IOP is an important risk factor for glaucoma progression. The objective of this work was to formulate and evaluate, in vitro and in vivo, a stable and effective Solid in Oil (S/O) topical formulation of the antiglaucoma drug, timolol maleate (TM). S/O dispersions were prepared by emulsification of aqueous TM solutions in cyclohexane using different amount of the span 85 then lyophilizing the emulsion to produce TM – Span 85 complexes. The complexes were then dispersed in castor oil using tip sonicator to produce S/O nanodispersions. S/O nanodispersions were evaluated in terms of particle size, polydispersity index, encapsulation efficiency, morphology, physical stability, as well as transcorneal permeation and accumulation of TM. In addition, the in vivo tolerability and efficacy of the prepared formulation in lowering intraocular pressure were evaluated in rabbits. \u0000Spherical nanoparticles of TM with a particle size of about 134-155 nm were successfully prepared and found to be physically stable. The encapsulation efficiency was high and was found to be dependent on the level of Span 85 used. \u0000In comparison to TM solution, S/O nanodispersion enhanced TM permeation and decreased accumulation in transcorneal diffusion studies. In addition, application TM S/O nanodispersion onto rabbit eyes resulted in a significant reduction in IOP in comparison to TM aqueous solution.","PeriodicalId":14719,"journal":{"name":"Jordan Journal of Pharmaceutical Sciences","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44313922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synthesis and Biological Evaluation of Carbonic Anhydrase III and IX Inhibitors using Gas Chromatography with Modified pH Sensitive Pellets 改性pH敏感颗粒气相色谱法合成碳酸酐酶III和IX抑制剂及其生物学评价
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-07-24 DOI: 10.35516/jjps.v16i2.1470
Buthaina Hussein, Laurance M S Bourghli, Muhammed Alzweiri, Y. Al-Hiari, Mohammad Abu Sini, Soraya Alnabulsi, Batool Al-Ghwairi
Fifteen compounds were synthesized and tested as potential carbonic anhydrase III (CAIII) and carbonic anhydrase IX (CAIX) inhibitors, six of which are novel. Amides (a1-4), hydroxamic acids (b1-2), and imines (c1-9) derivatives were evaluated for their inhibitory activity against CAII and CAIX using gas chromatography with modified pH-sensitive pellets. The derivatives showed inhibition percentages between 12-56% for CAIII and 44-59% for CAIX, compared to 49% and 63% for captopril (the positive control), respectively. Imines showed the best inhibition of CAIII, while all derivatives showed comparable activity against CAIX. It is hypothesized that the nitrogen atom in imine, amide, or hydroxamic acid moieties in the vicinity of an ionizable group is in coordination with the zinc ion in the active site. Furthermore, the candidates were tested for their antimicrobial and antifungal activity. Generally, they showed low to zero activity against some gram-positive and negative bacteria. This supports the theory of their ability to bind to human carbonic anhydrase but not to bacterial one. These compounds could serve as useful scaffolds to develop more potent and selective carbonic anhydrase inhibitors as anti-obesity and anticancer candidates.
合成并测试了15种化合物作为潜在的碳酸酐酶III(CAII)和碳酸酐酶IX(CAIX)抑制剂,其中6种是新的。酰胺(a1-4)、异羟肟酸(b1-2)和亚胺(c1-9)衍生物使用具有改性pH敏感颗粒的气相色谱法评估其对CAII和CAIX的抑制活性。衍生物对CAII的抑制率在12-56%和CAIX的抑制率为44-59%之间,而对卡托普利(阳性对照)的抑制率分别为49%和63%。亚胺对CAII表现出最好的抑制作用,而所有衍生物对CAIX都表现出相当的活性。假设可离子化基团附近的亚胺、酰胺或异羟肟酸部分中的氮原子与活性位点中的锌离子配位。此外,对候选药物的抗菌和抗真菌活性进行了测试。一般来说,它们对一些革兰氏阳性和阴性细菌显示出低至零的活性。这支持了它们与人类碳酸酐酶结合而不与细菌碳酸酐酶连接的理论。这些化合物可以作为有用的支架,开发更有效和选择性的碳酸酐酶抑制剂,作为抗肥胖和抗癌的候选药物。
{"title":"Synthesis and Biological Evaluation of Carbonic Anhydrase III and IX Inhibitors using Gas Chromatography with Modified pH Sensitive Pellets","authors":"Buthaina Hussein, Laurance M S Bourghli, Muhammed Alzweiri, Y. Al-Hiari, Mohammad Abu Sini, Soraya Alnabulsi, Batool Al-Ghwairi","doi":"10.35516/jjps.v16i2.1470","DOIUrl":"https://doi.org/10.35516/jjps.v16i2.1470","url":null,"abstract":"Fifteen compounds were synthesized and tested as potential carbonic anhydrase III (CAIII) and carbonic anhydrase IX (CAIX) inhibitors, six of which are novel. Amides (a1-4), hydroxamic acids (b1-2), and imines (c1-9) derivatives were evaluated for their inhibitory activity against CAII and CAIX using gas chromatography with modified pH-sensitive pellets. The derivatives showed inhibition percentages between 12-56% for CAIII and 44-59% for CAIX, compared to 49% and 63% for captopril (the positive control), respectively. Imines showed the best inhibition of CAIII, while all derivatives showed comparable activity against CAIX. It is hypothesized that the nitrogen atom in imine, amide, or hydroxamic acid moieties in the vicinity of an ionizable group is in coordination with the zinc ion in the active site. Furthermore, the candidates were tested for their antimicrobial and antifungal activity. Generally, they showed low to zero activity against some gram-positive and negative bacteria. This supports the theory of their ability to bind to human carbonic anhydrase but not to bacterial one. These compounds could serve as useful scaffolds to develop more potent and selective carbonic anhydrase inhibitors as anti-obesity and anticancer candidates.","PeriodicalId":14719,"journal":{"name":"Jordan Journal of Pharmaceutical Sciences","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42918588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification and Separation of the Degradation Products of Vildagliptin Tablets and Raw Material using LC-MS and NMR, and then Exploration of the Corresponding Degradation Pathways LC-MS和NMR对维达列汀片及其原料降解产物的鉴定、分离及其降解途径的探索
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-07-24 DOI: 10.35516/jjps.v16i2.1535
Enas Alqudah, Malak Abbadi, Sawsan Alqadoomi, Ibtihal Abo Hameda, S. Arar, K. Sweidan
A gradient high performance liquid chromatography (HPLC) method has been developed for the qualitative and quantitative analyses of vildagliptin related substances. This method is based on using of RP-C18 (250 × 4.6 mm×5µm) and gradient elution with phosphate buffer and methanol as mobile phase. Various forced degradation studies were conducted to establish an impurity profile for vildagliptin in the tablet formula. Three degradation products were produced upon exposing vildagliptin to different degradation conditions (acidic, basic, oxidative, photolytic, aqueous and thermal); their structures were characterized using LC-MS and NMR (1H NMR, 13C NMR and DEPT) techniques. Some excipient components, examined in this study, had major effect towards producing any extra new degradation products.
建立了一种梯度高效液相色谱法(HPLC)对维达列汀相关物质进行定性和定量分析。该方法以RP-C18(250×4.6mm×5µm)为流动相,以磷酸盐缓冲液和甲醇为流动相进行梯度洗脱。进行了各种强制降解研究,以确定片剂配方中维达格利汀的杂质分布。维达格列汀暴露于不同的降解条件(酸性、碱性、氧化性、光解性、水性和热性)后,产生了三种降解产物;使用LC-MS和NMR(1H NMR、13C NMR和DEPT)技术表征它们的结构。本研究中检查的一些赋形剂成分对产生任何额外的新降解产物具有主要影响。
{"title":"Identification and Separation of the Degradation Products of Vildagliptin Tablets and Raw Material using LC-MS and NMR, and then Exploration of the Corresponding Degradation Pathways","authors":"Enas Alqudah, Malak Abbadi, Sawsan Alqadoomi, Ibtihal Abo Hameda, S. Arar, K. Sweidan","doi":"10.35516/jjps.v16i2.1535","DOIUrl":"https://doi.org/10.35516/jjps.v16i2.1535","url":null,"abstract":"A gradient high performance liquid chromatography (HPLC) method has been developed for the qualitative and quantitative analyses of vildagliptin related substances. This method is based on using of RP-C18 (250 × 4.6 mm×5µm) and gradient elution with phosphate buffer and methanol as mobile phase. Various forced degradation studies were conducted to establish an impurity profile for vildagliptin in the tablet formula. Three degradation products were produced upon exposing vildagliptin to different degradation conditions (acidic, basic, oxidative, photolytic, aqueous and thermal); their structures were characterized using LC-MS and NMR (1H NMR, 13C NMR and DEPT) techniques. Some excipient components, examined in this study, had major effect towards producing any extra new degradation products.","PeriodicalId":14719,"journal":{"name":"Jordan Journal of Pharmaceutical Sciences","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45074463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Jordan Journal of Pharmaceutical Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1